Nov 29 |
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q
|
Nov 29 |
Eagle Pharmaceuticals Announces Management Change
|
Nov 27 |
Down -33.75% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround
|
Nov 17 |
Top 4 Health Care Stocks That Could Blast Off This Quarter
|
Nov 10 |
Down -26.73% in 4 Weeks, Here's Why Eagle Pharmaceuticals (EGRX) Looks Ripe for a Turnaround
|
Nov 9 |
Eagle Delays Third Quarter 2023 Results and Conference Call
|
Nov 8 |
Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023
|